Skip to main navigation Skip to search Skip to main content

Correction to: Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Middle East regions: PARACHUTE study (BMC Cancer, (2021), 21, 1, (1021), 10.1186/s12885-021-08738-z)

  • Mustafa Erman
  • , Bivas Biswas
  • , Pongwut Danchaivijitr
  • , Lingwu Chen
  • , Yoke Fui Wong
  • , Tarek Hashem
  • , Chun Sen Lim
  • , Bulent Karabulut
  • , Hsiao Jen Chung
  • , Chandrasekhar Chikatapu
  • , Sara Ingles
  • , Khemaies Slimane
  • , Ravindran Kanesvaran
  • Tata Medical Center
  • Mahidol University
  • First Affiliated Hospital of Sun Yat-Sen University
  • Radiotherapy and Oncology
  • Medical Oncology
  • Sultan Ismail Hospital
  • Ege University
  • National Yang Ming Chiao Tung University
  • Novartis
  • Novartis Pharma S.A.S.
  • National Cancer Centre

Research output: Contribution to journalComment/debate

3 Citations (Scopus)

Abstract

Following publication of the original article [1], the authors identified an error in the author names of Mustafa Erman, Bivas Biswas, Pongwut Danchaivijitr, Lingwu Chen and Chandrasekhar Chikatapu. The given names and family names were erroneously transposed. Further to this, figure 1 has been updated. The line colors in “C” section for “Poor” and “Unknown” have been changed to align with Figure B and legend to match the line colors. The author group has been updated above and the original article [1] has been corrected.

Original languageEnglish
Article number1191
JournalBMC Cancer
Volume21
Issue number1
DOIs
Publication statusPublished - Dec 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Correction to: Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Middle East regions: PARACHUTE study (BMC Cancer, (2021), 21, 1, (1021), 10.1186/s12885-021-08738-z)'. Together they form a unique fingerprint.

Cite this